Robert J. Fontana

Robert J. Fontana

University of Michigan-Dearborn

H-index: 101

North America-United States

About Robert J. Fontana

Robert J. Fontana, With an exceptional h-index of 101 and a recent h-index of 64 (since 2020), a distinguished researcher at University of Michigan-Dearborn, specializes in the field of hepatology.

His recent articles reflect a diverse array of research interests and contributions to the field:

Vancomycin-Induced Liver Injury, DRESS, and HLA-A∗ 32: 01

Amiodarone and Dronedarone Causes Liver Injury with Distinctly Different Clinical Presentations

Diagnosis and management of immune mediated liver injury from checkpoint inhibitors

MELD 3.0 in Advanced Chronic Liver Disease

Granulomatous hepatitis: Is it bugs, drugs, or other untoward culprits?

HDV screening in chronic HBV: An unmet need of growing importance

Incidence and predictors of hepatocellular carcinoma in patients with autoimmune hepatitis

Abstract No. 588 A Tale of Two Veins: Does the Right versus Middle Hepatic Vein Access Impact One-Year TIPS Patency?

Robert J. Fontana Information

University

Position

___

Citations(all)

50023

Citations(since 2020)

18241

Cited By

39213

hIndex(all)

101

hIndex(since 2020)

64

i10Index(all)

331

i10Index(since 2020)

229

Email

University Profile Page

Google Scholar

Robert J. Fontana Skills & Research Interests

hepatology

Top articles of Robert J. Fontana

Title

Journal

Author(s)

Publication Date

Vancomycin-Induced Liver Injury, DRESS, and HLA-A∗ 32: 01

The Journal of Allergy and Clinical Immunology: In Practice

Bilal A Asif

Christopher Koh

Elizabeth J Phillips

Jiezhun Gu

Yi-Ju Li

...

2024/1/1

Amiodarone and Dronedarone Causes Liver Injury with Distinctly Different Clinical Presentations

Digestive Diseases and Sciences

Alexander Pop

Dina Halegoua-DeMarzio

Huiman Barnhart

David Kleiner

Mark Avigan

...

2024/2/28

Diagnosis and management of immune mediated liver injury from checkpoint inhibitors

Alisa Likhitsup

Robert J Fontana

2024/2/16

MELD 3.0 in Advanced Chronic Liver Disease

Nikhilesh R Mazumder

Robert J Fontana

2024/1/29

Granulomatous hepatitis: Is it bugs, drugs, or other untoward culprits?

Neil Shah

Elie G Dib

Nora Joseph

Robert J Fontana

2024/1/1

HDV screening in chronic HBV: An unmet need of growing importance

Hepatology

Abhishek Shenoy

Robert J Fontana

2024/5/1

Incidence and predictors of hepatocellular carcinoma in patients with autoimmune hepatitis

Journal of Hepatology

Francesca Colapietro

Patrick Maisonneuve

Ellina Lytvyak

Ulrich Beuers

Robert C Verdonk

...

2024/1/1

Abstract No. 588 A Tale of Two Veins: Does the Right versus Middle Hepatic Vein Access Impact One-Year TIPS Patency?

Journal of Vascular and Interventional Radiology

V Khare

T Merritt

H Anbari

L Swanson

N Zbib

...

2024/3/1

AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury

Hepatology

Robert J Fontana

Iris Liou

Adrian Reuben

Ayako Suzuki

M Isabel Fiel

...

2023/3/1

Advances in the management of idiosyncratic drug-induced liver injury

Ahmed Memon

Amoah Yeboah-Korang

Robert J Fontana

2023/4/1

Safety and yield of percutaneous liver biopsy in adults and children with chronic hepatitis B: Results from a prospective, multicenter study

Hepatology Communications

Marc G Ghany

Steven H Belle

David E Kleiner

Coleman Smith

Stephanie S Kelley

...

2023/6/1

Positron emission tomography myocardial perfusion imaging (PET MPI) findings predictive of post-liver transplant major adverse cardiac events

Liver Transplantation

Dempsey L Hughes

Jason Pan

Adeline R Answine

Christopher J Sonnenday

Seth A Waits

...

2023/9/1

human liver organoid screening platform for DILI risk prediction

Charlie J Childs

Jason R Spence

Robert J Fontana

Jonathan Z Sexton

2023

Hematohepatology: The potential for direct oral anticoagulant “Inflation” in liver transplant candidates

Research and Practice in Thrombosis and Haemostasis

Jordan K Schaefer

Robert J Fontana

2023/2

Early initiation of glecaprevir/pibrentasvir after transplantation of HCV‐viremic kidneys into HCV‐negative recipients is associated with normalization in the altered …

Clinical Transplantation

Myung‐Ho Kim

Meghan E Sise

Min Xu

David S Goldberg

Robert J Fontana

...

2023/4

Successful living donor liver transplantation in a patient with hemophilia A and factor VIII inhibitor: A case report with perioperative recommendations

American Journal of Transplantation

Reed W Kamyszek

Suman L Sood

Christopher J Sonnenday

Neehar D Parikh

Amanda Westman

...

2023/6/1

The impact of patient age and corticosteroids in patients with Sulfonamide hepatotoxicity

Official journal of the American College of Gastroenterology| ACG

Robert J Fontana

David E Kleiner

Naga Chalasani

Herbert Bonkovsky

Jiezhun Gu

...

2023/9/1

Symptoms of Liver Disease During Tenofovir Therapy With or Without Peginterferon: Results from the Hepatitis B Research Network Immune Active Trial

Digestive Diseases and Sciences

Donna M Evon

Hsing-Hua S Lin

Mandana Khalili

Abdus S Wahed

Colina Yim

...

2023/12

Serum proteomics to characterize adult patients with Acute Liver Failure

Zeitschrift für Gastroenterologie

Katharina Remih

Franziska-Maria Hufnagel

Valerie Durkalski-Mauldin

William Martens Lee

Zemin Su

...

2023/1

PRO: Liver transplantation for intrahepatic cholangiocarcinoma

Abhishek Shenoy

Jason J Pan

Robert J Fontana

2023/2/1

See List of Professors in Robert J. Fontana University(University of Michigan-Dearborn)